$ABBV AbbVie Q3 Earnings
Adj. EPS $3.82, est. $3.74
Net rev. $17.40B, est. $17.34B
Skyrizi rev. $5.78B, est. $5.74B
Rinvoq rev. $2.71B, est. $2.70B
Humira rev. $683M, est. $679.3M
Imbruvica rev. $522M, est. $527.3M
Sees FY Adj. EPS $13.95 to $13.99, saw $13.76 to $13.96